Publications by authors named "C Marth"

Claim this Profile
A
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.
Philipp Harter, Frederik Marmé, Andrés Redondo, Alexander Reuss, Kristina Lindemann, Christian Marth

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of -Mutated High-Grade Serous Ovarian Cancer.
Katharina Steger, Heidelinde Fiegl, Katja Rungger, Katharina Leitner, Irina Tsibulak, Christian Marth

Cancers (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.
Christoph Ebner, Ricarda Purtscheller, Barin Feroz, Jana Rieker, Linda Ebner, Christian Marth

Acta Obstet Gynecol Scand· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Letter to the Editor "Long-term follow-up of PAOLA-1 and the evolving landscape of post-PARP treatment strategies in ovarian cancer" by Arenhardt and Nogueira-Rodrigues.
I Ray-Coquard, C Cropet, P Harter, E Pujade-Lauraine, C Marth

Ann Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are brain metastases a special issue in POLE-mutated endometrial cancer? a case report series.
Christoph Ebner, Kristina Lindemann, Gunnar Kristensen, Alice Frosch, Hanne Askautrud, Christian Marth

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis